Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Hexagon Purus receives inaugural orders for hydrogen cylinders from Reliance Industries Limited in India

Hexagon Purus, a world leading supplier of zero emission mobility solutions, has received its first orders for Type 4 high-pressure hydrogen cylinders from Reliance Industries Limited (“Reliance”), India’s largest private sector company. The hydrogen cylinders will be used as prototypes in pilot projects for automotive and back-up power solutions and represents Hexagon Purus’ first ever orders for hydrogen applications in India. The orders represent Reliance’s first step towards positioning themselves as a leading clean energy player, supporting the transition to a zero-emission society

Fund manager Estea AB targets increased growth together with Magnus Nordholm as partner and co-owner

Estea adopts a new strategy to grow its investment business. The goal is to develop and build on the company's strong track record, which for over 20 years has made it secure, easy and profitable for private and institutional investors to invest in real estate. Estea's investment offering will be further broadened towards institutions and also include the growing segment of infrastructure. The range of fund products will be expanded, with new institutional products, more funds for private investors and an increased focus on ESG. "The strong focus on quality throughout the value chain

COO Pernilla Sandwall is leaving InDex Pharmaceuticals for a CEO position

February 13, 2022 – InDex Pharmaceuticals Holding AB (publ) today announced that Chief Operating Officer Pernilla Sandwall has decided to leave the company to become CEO of WntResearch. She will continue in her current role until the end of April. The process to recruit her successor will be initiated immediately.“In her ten years at InDex, Pernilla has successfully built up a highly qualified and effective development organisation, which ensures that the work to take the drug candidate cobitolimod through phase III will continue according to plan. Phase III is the final stage of

Magnus Larsson appointed new acting CEO of Pricer

The Board of Directors of Pricer has appointed Magnus Larsson as acting CEO of Pricer AB.Magnus Larsson has been Vice President Customer Operations at Pricer since he joined the company in 2019 and is a member of the management team. He succeeds Magnus Midgard as acting CEO who succeeded Helena Holmgren who recently left the company after leading it for almost five years. “The entire board and I are very satisfied and feel confident about the appointment of Magnus Larsson as acting CEO. Magnus has worked for Pricer for three years and during that time he has successfully developed Pricer’

Norway Royal Salmon ASA (NRS): Biological challenges in Dyrafjordur for the subsidiary Arctic Fish in Iceland

Arctic Fish has been experiencing severe biological issues in two of its sites in Dyrafjordur, Iceland. The total estimation of mortality is under review but is estimated to be 1.5-2.0 thousand tonnes of large size fish that was ready for the market.  All efforts are being made to handle this efficiently, which include speeding up harvesting in these two sites in the coming weeks.  Our excellent employees in Iceland have made great efforts in handling the situation in the best possible manner. The main root cause for the mortality is related to reduced fish health, which could have been

ADDvise acquires Poly Pharmaceuticals, Inc.

ADDvise Group AB has today entered into a share purchase agreement with the shareholders of Poly Pharmaceuticals, Inc. (“Poly Pharma”) regarding the acquisition of all the outstanding shares of Poly Pharma in accordance with the letter of intent communicated via a press release dated October 21, 2021. Closing of the acquisition will take place during the first quarter 2022. Poly Pharma’s revenue for the last twelve months (LTM) per September 30, 2021, amounted to approximately USD 8.3 million, with an EBITDA of approximately USD 2.0 million, corresponding to an EBITDA margin of

Publication of the NAXS 2021 Annual Report

Stockholm, February 11, 2022 PRESS RELEASE - NAXS AB (publ) Not for release, publication or distribution, directly or indirectly, in or into the United States, Hong Kong, Canada, Japan or Australia, or any other jurisdiction in which the distribution or release would be unlawful. The NAXS 2021 Annual Report for is now available on the Company’s website, www.naxs.se. The Annual Report is also attached to this notice. Contact information: Lennart Svantesson, CEO Telephone: +46 73 311 00 11 This information is information that NAXS AB (publ) is obliged to make public

Nordea Bank Abp: Repurchase of own shares on 11.02.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares11.02.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 11.02.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XSTO 949,598 10.53 10,003,245.54XHEL 680,712 10.51 7,156,189.11CEUX 904,527 10.52 9,518,893.00AQEU 89,738 10.53

Össur hf: Össur Initiates a New Share Buyback Program

Announcement no. 05/2022 11 February 2022 Össur hf. has decided to initiate a new share buyback program (the “Program”) on Monday, 14 February 2022. The Program will be carried out in accordance with Regulation No. 596/2014 of the European Parliament and of the Council on market abuse ("MAR"), and the Commission’s delegated regulation 2016/1052. The purpose of the Program is to reduce the Company’s share capital and adjust the capital structure by distributing capital to shareholders in line with the Company’s Capital Structure and Capital Allocation Policy. The Company may purchase

SRV Group Plc: Repurchase of own shares on 11 February 2022

SRV GROUP PLC     STOCK EXCHANGE RELEASE     11 FEBRUARY 2022      18:45 EET   SRV Group Plc repurchase of own shares on 11.02.2022     +------------------------+----------+|SRV Group Plc |  |+------------------------+----------+|In the Nasdaq Helsinki |  |+------------------------+----------+|Date |11.02.2022|+------------------------+----------+|Exchange transaction |BUY |+------------------------+----------+|Share trading code |SRV1V |+------------------------+----------+|Amount, shares

Valmet Oyj: Acquisition of own shares 11.02.2022

Valmet Oyj: Acquisition of own shares 11.02.2022 Valmet Oyj's stock exchange release on February 11, 2022 at 06:30 p.m. EET  Date 11.02.2022Exchange transaction BuyShare class VALMTAmount 15,000Average price/share 32.5295 EURHighest price/share 32.8100 EURLowest price/share 32.0900 EURTotal price 487,942.50 EUR The shares held by Valmet Oyj on 11.02.2022: VALMT 438,423 On behalf of Valmet Oyj  Skandinaviska Enskilda Banken AB (Publ) Antti Salakka         Janne Tiihonen For

#22-49 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on phone +46 8 566 390 20 or listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a

Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties

Valby, Denmark, 11 February 2022 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. +--+-----------------+----------+---------+|1.|Details of the || |person || |discharging || |managerial || |responsibilities || |/ person closely || |associated |+--+-----------------+--

Director/PDMR Shareholding

11 February 2022 15:30 GMT Transaction by Person Discharging Managerial Responsibilities AstraZeneca PLC (the Company) announced that, on 10 February 2022, an award of the Company's ordinary shares of $0.25 each (Ordinary Shares) under the AstraZeneca Investment Plan (AZIP) vested to Pascal Soriot, Chief Executive Officer. The AZIP award was granted on 28 March 2014 and was subject to a four-year performance period followed by a four-year holding period before vesting. Application of the performance measures specified at the time of grant resulted in 100% of the AZIP award entering

Acquisition of shares by primary insiders

Oslo, 11 February 2022 Today, 11 February 2022, a total of 9,704 shares in DNB Bank ASA were acquired on behalf of certain of DNB’s primary insiders, who are part of the Group Management team. The share purchase was executed collectively at an average price per share of NOK 212.7924 The shares were purchased in accordance with the share programme that was approved by the Annual General Meeting on 30 June 2020. Shares that are acquired through the programme have a holding period, which lasts for as long as the person holding the shares is part of the Group Management team. Upon leaving

Scandinavian ChemoTech's subsidiary Vetiqure AB signs agreements with three AniCura clinics

The agreement between Vetiqure AB and three AniCura clinics is regarding a collaboration for TSE treatment of soft tissue sarcoma in dogs.Through this agreement, Vetiqure AB has started a collaboration with three AniCura clinics, two in Sweden and one in Norway with the aim of studying the outcome of treatment with the company's Tumour Specific Electroporation, TSE ™, for soft tissue sarcoma in dogs. The project is run by Lic. veterinarian Nanna Åkerlund Denneberg, oncology specialist in dog and cat at AniCura Animal Hospital Jönköping. Also participating is Lic. veterinarian Marianne

NRC GROUP ASA - APPOINTED TO A CONTRACT IN NORWAY - NOK 51 MILLION

Bane NOR has appointed NRC Norge AS, a company wholly owned by NRC Group ASA, to a contract for rehabilitation and upgrading of the railway infrastructure between Etterstad and Lillestrøm. The contract is valued at approximately NOK 51 million, and will involve rail services such as track, electro, signal/telecom and groundwork. The work will commence in March 2022, and the project is scheduled for completion in March 2023. Closing date for submission of complaints is 10 days from today, and formal contractual signing can take place after this period at the earliest. For further

Mandatory notification of trade by Primary Insiders

Pexip Holding ASA ("Pexip" or "The Company", Oslo Børs Ticker: PEXIP) has today been notified that these transactions have been completed by primary insiders in Pexip: Patricia Auseth, SVP of Purpose and Business Development, has today, February 11, 2022, bought 1,820 shares at NOK 39.30 per share. After the transaction, Patricia Auseth will hold 1,820 shares and rights to 15,000 shares. The information included in this announcement is such that the Company is required to disclose in accordance with the EU Market Abuse Regulation (MAR) and is publicly disclosed in accordance with MAR

Invitation to presentation of Storytel AB’s Q4 Report 2021

On 18 February 2022 at 8.00 AM CET, Storytel AB will publish its Q4 Report for 2021. Storytel AB will hold a presentation of the report on the same day and invites investors, analysts and media to a webcast at 10.30 AM CET. The presentation will be in English and followed by a Q&A with Storytel’s founder and CEO Jonas Tellander, Chief Commercial Officer Ingrid Bojner and Chief Financial Officer Sofie Zettergren.The Q4 Report for 2021 will be available here  at 8.00 AM CET on 18 February.Information to

Webstep ASA: Invitation to presentation of financial reports Q4 2021

Oslo, 11 February 2022:  Please note that Webstep ASA will announce its fourth quarter 2021 results Thursday, 17 February 2022.The fourth quarter 2021 presentation will be available via the following webcast link at 9:00 am CET the same day: https://channel.royalcast.com/landingpage/hegnarmedia/20220216_1/ The interim report and presentation will be available from 7:00 am CET the same day at: https://investor.webstep.com/Investors/reports-and-presentations/default.aspx

Artificial Solutions: Invitation to presentation of Q4 report 2021

Artificial Solutions® (SSME:ASAI), the leading specialist in enterprise-strength conversational AI, will release the interim report for the fourth quarter of 2021 on Thursday 17th February at 07:30 am (CET).The full report and a brief presentation will be available on: https://www.investors.artificial-solutions.com/financial-reports. Conference Call – details Per Ottosson, CEO and Fredrik Törgren, CFO will present the financial results at a telephone conference at 10:00 CET on the same day. In order to participate in the conference call, please use the dial-in details below. Callers

Gaming Innovation Group extends contract with Betsson Group

Gaming Innovation Group Inc. (GiG) has today signed an extension to the long-term agreement with Betsson Group for the provision of Platform & Managed Services, which include Customer Service and full business operations across multiple territories. The contract extension is for an additional three years taking the term of the contract to Q4 2025. The agreement includes the brands Rizk, Guts, Kaboo and Thrills, and includes managed services to Betsson for support of operations of the brands. GiG will also deliver several new growth market entries as part of the agreement, which is a

LUCARA 2021 YEAR END RESULTS TO BE RELEASED THURSDAY, FEBRUARY 24, 2022

February 11, 2022 Vancouver, British Columbia /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm) Lucara Diamond Corp. (“Lucara” or the “Company”) announces that it will be publishing its 2021 Year End Results on Thursday, February 24, 2022 after market close in North America.  The Company will host a conference call and webcast to discuss the results on Friday, February 25, 2022 at 7:00am Pacific, 10:00am Eastern, 3:00pm UK, 4:00pm CET. CONFERENCE CALL:Please call in 10 minutes before the conference call starts and stay on the line (an operator will be available to assist you).

There are no items matching the current filter
There are no more items matching the current filter
Back to top